Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin-Reference-Cited by-同舟云学术

Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin

Published:2011-12-21 Issue:3 Volume:87 Page:277-283
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Ramakrishnan Vijay,Timm Michael,Haug Jessica L.,Kimlinger Teresa K.,Halling Timothy,Wellik Linda E.,Witzig Thomas E.,Vincent Rajkumar S.,Adjei Alex A.,Kumar Shaji

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.22263/fullpdf

Reference42 articles.

1. Tumor angiogenesis: Therapeutic implications;Folkman;N Engl J Med,1971

2. Angiogenesis: An organizing principle for drug discovery?;Folkman;Nat Rev Drug Discov,2007

3. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas;Vacca;Br J Cancer,1999

4. Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression;Kumar;Blood,2004

5. Prognostic value of bone marrow angiogenesis in multiple myeloma;Rajkumar;Clin Cancer Res,2000

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway;Oncology Reports;2023-06-13

2. Low Temperature Plasma Suppresses Lung Cancer Cells Growth via VEGF/VEGFR2/RAS/ERK Axis;Molecules;2022-09-13

3. KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders;Cancers;2022-01-28

4. Incidence and computed tomography findings of lenvatinib-induced pancreatobiliary inflammation;Medicine;2021-09-03

5. Signaling Pathway Mediating Myeloma Cell Growth and Survival;Cancers;2021-01-08